J Virol. 1987 February; 61(2): 499-508
Epstein-Barr virus glycoprotein homologous to herpes simplex virus gB.
M Gong,
T Ooka,
T Matsuo and
E Kieff
ABSTRACT
The Epstein-Barr virus DNA open reading frame BALF4 (R. Baer, A.T. Bankier, M.D. Biggin, P.L. Deininger, P.J. Farrell, T.J. Gibson, G. Hatfull, G.S. Hudson, S.C. Stachwell, C. Sequin, P.S. Tuffnell, and B.G. Barrell, Nature [London] 310:207-211, 1984), which by nucleotide sequence comparison could encode a protein similar to herpes simplex virus gB (P.E. Pellett, M.D. Biggin, B. Barrell, and B. Roizman, J. Virol. 56:807-813, 1985), has now been shown to encode a 110-kilodalton glycoprotein. Late infectious cycle RNAs of 3.0 and 1.8 kilobases are transcribed from BALF4. Translation of these RNAs in vitro, transcription and translation of BALF4 in vitro, or metabolic labeling of cells in the presence of tunicamycin and immunoprecipitation with BALF4-specific sera results in identification of a 93-kilodalton precursor to gp110. Since N-glycosidase F only reduces the size of gp110 to 105 kilodaltons, gp110 probably has both N- and O-linked glycosylation, gp110 is an abundant glycoprotein in Epstein-Barr virus-infected cells. In infected lymphocytes and in 3T3 cells, in which the gene is expressed from a recombinant expression vector, most of the protein is cytoplasmic and perinuclear. In contrast to gB, gp110 was not detected in the infected-cell plasma membrane. In cells replicating Epstein-Barr virus, gp110 localized to the inner and outer nuclear membrane lamellae and to endoplasmic reticulum structures which sometimes contained enveloped virus. gp110 may play an important role in modifying infected intracellular membranes.
J Virol. 1987 February; 61(2): 499-508
This article has been cited by other articles:
-
Klupp, B., Altenschmidt, J., Granzow, H., Fuchs, W., Mettenleiter, T. C.
(2008). Glycoproteins Required for Entry Are Not Necessary for Egress of Pseudorabies Virus. J. Virol.
82: 6299-6309
[Abstract]
[Full Text]
-
Gu, A.-D., Xie, Y.-B., Mo, H.-Y., Jia, W.-H., Li, M.-Y., Li, M., Chen, L.-Z., Feng, Q.-S., Liu, Q., Qian, C.-N., Zeng, Y.-X.
(2008). Antibodies against Epstein-Barr virus gp78 antigen: a novel marker for serological diagnosis of nasopharyngeal carcinoma detected by xMAP technology. J. Gen. Virol.
89: 1152-1158
[Abstract]
[Full Text]
-
Okazaki, K.
(2007). Proteolytic cleavage of glycoprotein B is dispensable for in vitro replication, but required for syncytium formation of pseudorabies virus. J. Gen. Virol.
88: 1859-1865
[Abstract]
[Full Text]
-
Keil, G. M., Hohle, C., Giesow, K., Konig, P.
(2005). Engineering Glycoprotein B of Bovine Herpesvirus 1 To Function as Transporter for Secreted Proteins: a New Protein Expression Approach. J. Virol.
79: 791-799
[Abstract]
[Full Text]
-
McShane, M. P., Longnecker, R.
(2004). Cell-surface expression of a mutated Epstein-Barr virus glycoprotein B allows fusion independent of other viral proteins. Proc. Natl. Acad. Sci. USA
101: 17474-17479
[Abstract]
[Full Text]
-
Neuhierl, B., Feederle, R., Hammerschmidt, W., Delecluse, H. J.
(2002). Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection. Proc. Natl. Acad. Sci. USA
99: 15036-15041
[Abstract]
[Full Text]
-
Strive, T., Borst, E., Messerle, M., Radsak, K.
(2002). Proteolytic Processing of Human Cytomegalovirus Glycoprotein B Is Dispensable for Viral Growth in Culture. J. Virol.
76: 1252-1264
[Abstract]
[Full Text]
-
Toussirot, E., Wendling, D., Tiberghien, P., Luka, J., Roudier, J.
(2000). Decreased T cell precursor frequencies to Epstein-Barr virus glycoprotein gp110 in peripheral blood correlate with disease activity and severity in patients with rheumatoid arthritis. Ann Rheum Dis
59: 533-538
[Abstract]
[Full Text]
-
Lake, C. M., Molesworth, S. J., Hutt-Fletcher, L. M.
(1998). The Epstein-Barr Virus (EBV) gN Homolog BLRF1 Encodes a 15-Kilodalton Glycoprotein That Cannot Be Authentically Processed unless It Is Coexpressed with the EBV gM Homolog BBRF3. J. Virol.
72: 5559-5564
[Abstract]
[Full Text]
Copyright © 1987 by the American Society for Microbiology. All rights reserved.